作者:Florian Dehmel、Thomas Ciossek、Thomas Maier、Steffen Weinbrenner、Beate Schmidt、Martin Zoche、Thomas Beckers
DOI:10.1016/j.bmcl.2007.06.063
日期:2007.9
class I/II enzymes is a new, promising approach for cancer therapy. In the present study, we disclose a new structural class of HDAC inhibitors with the trithiocarbonate motif. A clear structure-activity-relationship was obtained for the cap-linker motif and the putative Zn(2+) complexing head group. Selected analogs display potent inhibition of HDAC enzymatic activity and a cellular potency comparable
抑制组蛋白脱乙酰基酶I / II类酶是一种新的,有前途的癌症治疗方法。在本研究中,我们公开了具有三硫代碳酸酯基序的HDAC抑制剂的新结构类别。明确的结构-活性-关系获得了帽连接基序和假定的Zn(2+)络合头基。所选类似物显示出对HDAC酶活性的有效抑制作用,并且具有与最近被批准用于治疗晚期皮肤T细胞淋巴瘤的辛二酰苯胺异羟肟酸(SAHA)相当的细胞效价。